DKK1 and breast carcinoma: A novel molecule known as dorsomorphin has been shown to significantly reduce both mRNA and protein levels of DKK1 in breast cancer cells, suggesting that it could be an effective treatment for breast cancer (Li et al., 2015; Kasoha et al., 2018).